Deutsche Bank
RAPT

Deutsche Bank’s RAPT Therapeutics RAPT Stock Holding History

Deutsche Bank’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-34,354
Closed -$335K – 3713
2025
Q1 		$335K Sell
34,354
-167
-0.5% -$1.64K ﹤0.01% 2694
2024
Q4 		$436K Sell
34,521
-1,160
-3% -$14.7K ﹤0.01% 2678
2024
Q3 		$574K Sell
35,681
-80,887
-69% -$1.64M ﹤0.01% 2386
2024
Q2 		$2.84M Buy
116,568
+80,379
+222% +$3.71M ﹤0.01% 1468
2024
Q1 		$2.6M Sell
36,189
-80
-0.2% -$11.1K ﹤0.01% 1538
2023
Q4 		$7.21M Buy
36,269
+34,320
+1,761% +$4.25M ﹤0.01% 1115
2023
Q3 		$259K Sell
1,949
-34,105
-95% -$5.57M ﹤0.01% 2604
2023
Q2 		$5.39M Sell
36,054
-933
-3% -$145K ﹤0.01% 1206
2023
Q1 		$5.43M Buy
36,987
+1,220
+3% +$247K ﹤0.01% 1208
2022
Q4 		$5.67M Buy
35,767
+21
+0.1% +$3.36K ﹤0.01% 1172
2022
Q3 		$6.88M Sell
35,746
-393
-1% -$74.3K ﹤0.01% 1095
2022
Q2 		$5.28M Buy
36,139
+97
+0.3% +$12.9K ﹤0.01% 1253
2022
Q1 		$6.34M Sell
36,042
-2,937
-8% -$555K ﹤0.01% 1293
2021
Q4 		$11.5M Buy
38,979
+37,130
+2,008% +$9.92M 0.01% 1047
2021
Q3 		$460K Buy
1,849
+256
+16% +$67.7K ﹤0.01% 3092
2021
Q2 		$405K Sell
1,593
-7,027
-82% -$1.31M ﹤0.01% 3356
2021
Q1 		$1.53M Buy
8,620
+5,647
+190% +$931K ﹤0.01% 2375
2020
Q4 		$470K Buy
2,973
+2,211
+290% +$481K ﹤0.01% 2948
2020
Q3 		$196K Buy
762
+67
+10% +$14.9K ﹤0.01% 3228
2020
Q2 		$162K Buy
695
+634
+1,039% +$98K ﹤0.01% 3232
2020
Q1 		$10K Sell
61
-4
-6% -$911 ﹤0.01% 4060
2019
Q4 		$14K Buy
+65
New +$12K ﹤0.01% 4408

Other funds holding RAPT

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Deutsche Bank's RAPT Position: Q2 2025 in Review

Deutsche Bank sold out of RAPT Therapeutics (RAPT) in Q2 2025, closing a stake of 34,354 shares — an estimated $335K sold.

Deutsche Bank first reported a position in RAPT in Q4 2019 and held it in 22 quarters. The position peaked at $11.5M in Q4 2021. 50 funds tracked by Wall St. Rank hold RAPT as of Q2 2025.

  • Deutsche Bank reported no remaining RAPT Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Deutsche Bank sold 34,354 RAPT Therapeutics shares in Q2 2025, an estimated $335K.
  • Deutsche Bank first reported a position in RAPT Therapeutics in Q4 2019 and held it in 22 quarters.
  • Deutsche Bank's RAPT Therapeutics position peaked at $11.5M in Q4 2021.
  • 50 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q2 2025.

Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.